Pfizer and Merck: Earnings Face-Off

Pfizer and Merck have done a good job beating Wall Street's per-share expectations in the face of real headwinds. Pfizer has gone through a dramatic reorganization to fight this challenge, while Merck is standing pat with its more diverse business model.

In this video, health-care analyst David Williamson discusses both companies second-quarter results in greater detail, how their different approaches are working out, and what key drugs in their respective pipelines investors should focus on.

One of the best parts of owning big pharma stocks is their attractive dividends, but smart investors know the importance of diversifying -- seeking high-yielding stocks from multiple industries. The Motley Fool's special free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks across all sectors. Grab your free copy by clicking here.

Read/Post Comments (2) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 01, 2013, at 7:55 AM, EllenBrandtPhD wrote:

    Written early Thursday morning:

    Thank you and thank you - and thank you - to whomever identified Mr. Yacktman as the quintessential "big sloppy seller" this morning.

    As we all know, this kind of identification is almost always what you look for before a Big - widely-held - stock like PFE is allowed to make its move up.

    This is a volatile week and a possibly volatile month, so there will be setbacks.

    But now, those big options bets looking for 34 or 35 eventually may be back on the table.

    In any case, this is an exact parallel to what happened with Ford stock last September.

  • Report this Comment On August 01, 2013, at 11:35 AM, EllenBrandtPhD wrote:

    I believe some Cronies got so upset at that comment, they decided to escalate the baby games into a veritable Food Fight for Toddlers.

    No matter.

    If we are indeed approaching a good solid Bull Market again, it is high time worldwide investors and traders put our collective feet down and said, "Basta! No Mas! End the Reign of Cronyism Forever."

    Let Markets return to being decided by everyone involved, not just a handful of the Deepest Pockets fighting like gladiators against each other - or in some rare cases, against itsy bitsy adorable little Birds.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2571276, ~/Articles/ArticleHandler.aspx, 9/28/2016 6:46:34 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 9 hours ago Sponsored by:
DOW 18,228.30 133.47 0.74%
S&P 500 2,159.93 13.83 0.64%
NASD 5,305.71 48.22 0.92%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/27/2016 4:00 PM
MRK $62.57 Up +0.42 +0.68%
Merck and Co. CAPS Rating: ****
PFE $33.83 Up +0.19 +0.56%
Pfizer CAPS Rating: ****